Technology platforms for molecular diagnosis of cystic fibrosis.

doi:10.1016/j.biotechadv.2005.08.003

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Back to search

Article

Technology platforms for molecular diagnosis of cystic fibrosis.

Biotechnology advances - 1 Jan 2000

Eshaque Bithi, Dixon Brian

Abstract excerpt

Cystic fibrosis (CF) is one of the most common recessive genetic diseases in North America. So far, 1200 mutations causing CF have been identified. Several techniques such as allele specific oligonucleotide (ASO) dot-blot, reverse dot-blot, amplification refractory mutation (ARMS), and an oligo-ligation assay, are available to detect the most common mutations. However, detecting compound heterozygotes between...

Topics

Cystic Fibrosis
Microarray Analysis
Microspheres
Mutation
Proteomics

Source

Open in PubMed

Identifiers

PMID: 16171966
DOI: 10.1016/j.biotechadv.2005.08.003

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 30 Aug 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

discussions

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics